Global Genomic Medicine Collaborative
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 220,000 | 108,174 | 111,826 | 24.8 | 0% |
| 2018 | 608,798 | 343,015 | 265,783 | 17.1 | 0% |
| 2019 | 329,000 | 406,361 | −77,361 | 12.2 | 0% |
| 2020 | 917,522 | 697,876 | 219,646 | 10.9 | 0% |
| 2021 | 1,687,021 | 955,203 | 731,818 | 17.1 | 0% |
| 2022 | 952,070 | 1,082,162 | −130,092 | 13.7 | 0% |
| 2023 | 226,540 | 1,183,266 | −956,726 | 2.8 | 0% |
In its most recent public year (2023), this organization spent $956,726 more than it brought in. Its reserves stood at about 2.8 months of spending, down from 24.8 in 2017. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works